openwiki-wiki/themes/05-robin-research.md

type, title, description, tags, timestamp

type	title	description	tags	timestamp
Reference	Theme 5 · Robin's personal research (vendor deep reads + sales ammunition + CRM)	Synthesis page for Robin's personal research portfolio — Obsidian vault + literature deep-read pipeline + sales ammunition + China distributor map + active CRM profiles + work-rhythm snapshots. Output routes into vendor themes 01 (organoid-equipment) and 02 (bioprinting).	theme research vault deep-read sales crm life-sciences 2026-08-22 2026-08-21 2026-08-20 2026-08-19 2026-08-18 2026-08-17 2026-08-15 2026-08-13	2026-08-22T18:13:00Z

Theme 5 · Robin's personal research (vendor deep reads + sales ammunition + CRM)

This is the synthesis page for Robin 个人研究项目 — the durable body of work Robin builds on the 4-vendor product line: vendor-paper deep reads, vendor whitepaper deep reads, sales ammunition (pricing + protocols + app notes), the China distributor map, the active CRM profile set, and the weekly work-rhythm snapshot. Output is fed back into the vendor themes (/themes/01-organoid-equipment.md and /themes/02-bioprinting.md) and into /commitments.md.

What this theme covers

• Research identity & scope: 4 vendor product lines (CelVivo / 3Brain / Cellink / Femtobiomed) + adjacent application domains (MSC spheroids, PDO, brain organoids, hMOs, assembloids, 3D bioprinting, electroporation).
• Knowledge substrate: Obsidian vault rooted at /mnt/c/Users/20864/.openclaw/workspace (per ~/.openwiki/connectors/git-repo/config.json), HEAD 1a81e485, ahead of origin/main by 9 commits.
• Research process: LDR master template + SOP-vs-implementation lessons (Tasevska / Raji / Bosnjakovic as canonical worked examples).
• Research output: 1,202 deep-read notes in 04-Literature/Deep-Reads/ + sales training material in 06-Sales/Content/Training-Materials/ + active CelVivo industrial-customers program.
• CRM + market research: 1 active distributor profile (02-Clients/Agents/董慧群.md) + 261-dealer China map + 11+ end-customer dossiers under 03-Resources/End-Customers/.
• Work-rhythm evidence: 2026-07-16 vault mtime snapshot showing Robin's actual activity cadence across deep reads / training material / daily / weekly reports.

Research output — data model

erDiagram
    VAULT["Obsidian vault (a4fa5a32)"] ||--o{ DEEPREADS["Deep-read notes ~1,207"]
    VAULT ||--o{ TRAIN["Sales training (CelVivo赋能培训 v1-v9)"]
    VAULT ||--o{ SALES["Active sales pipeline (惠百生物 PO + 中间商)"]
    VAULT ||--o{ CRM["Distributor profiles (董慧群 + 待补)"]
    VAULT ||--o{ ENDCUST["End-customer dossiers (11+ 神经/中药/肿瘤所)"]
    VAULT ||--o{ INDUSTRIAL["Industrial customers (CelVivo中国工业客户开发)"]
    VAULT ||--o{ MEMORY["Daily + weekly reports (memory/ 147 .md)"]
    VAULT ||--o{ ITX["ITX 24h host build (untracked)"]
    VAULT ||--o{ MOC["MOCs (类器官与3D培养 first, +planned)"]
    VAULT ||--o{ TEMPLATES["Templates (类器官IRB申请清单 v1.0, untracked)"]

    DEEPREADS }o--|| VENDOR["Vendor mapping"]
    VENDOR ||--|{ CelVivo["CelVivo (ClinoStar / ClinoReactor)"]
    VENDOR ||--|{ ThreeBrain["3Brain (BioCAM / Accura-3D / CorePlate)"]
    VENDOR ||--|{ Cellink["Cellink (BIO X / BIONOVA X / Lumen X)"]
    VENDOR ||--|{ Femtobiomed["Femtobiomed (CellShot / TriArm / CellPick)"]

    SALES }o--|| CelVivo
    CRM }o--|| CelVivo
    ENDCUST }o--|| ThreeBrain
    INDUSTRIAL }o--|| CelVivo
    TRAIN }o--|| CelVivo

The diagram shows Robin's research substrate: a single Obsidian vault with 8 buckets of artifacts, most of which are vendor-anchored to one of the 4 product lines. Vendor-anchored output flows out of the vault and into the canonical synthesis themes (01 CelVivo / 3Brain; 02 Cellink; with Femtobiomed as adjacent cross-sell for both).

Knowledge substrate: Obsidian vault

Snapshot from /sources/git-repo.md (last fetch 2026-08-22T18:13:00Z):

Field	Value
Repo path	/home/ldw/workspace
Branch	main
HEAD	a4fa5a323d6dcabeb9eccad49e636ee6ba5f87a6 (unchanged at the 2026-08-22T18:13Z fetch — 0 new vault commits in the 2026-08-21T18:09Z → 2026-08-22T18:13Z 24-hour window; vault is silent for the 6th consecutive fetch after the 2026-08-17T18:09Z + 2026-08-18T18:10Z + 2026-08-19T18:08Z + 2026-08-20T18:09Z + 2026-08-21T18:09Z silent windows; 6 calendar days stale since the last vault HEAD bump on 2026-08-16; the 2026-08-16 Quintard 2024 Nat Commun 4-commit LDR cycle + Guo 2026 Front Cell Dev Biol 3-commit LDR cycle remain the most recent vault activity)
Ahead of origin/main	20 commits new since 2026-08-03 fetch (unchanged from the 2026-08-17 + 2026-08-18 + 2026-08-19 + 2026-08-20 + 2026-08-21 + 2026-08-22 fetches)
Auth	local path only — no remote, no credentials
Working-tree state	dirty (23 untracked files + 2 new untracked directories — celvivo_commercial/1331651_20260630_131201.pdf + templates/类器官IRB申请清单.md — both untracked; the Review/zhou2023_computer_vision_microfluidics.md first-entry-in-Review/-subfolder is still-uncommitted, carrying forward from the 2026-08-13 fetch, 11-day carry-forward at the 2026-08-22T18:13Z fetch — 9 fetches silent on the file)
Raw manifest	~/.openwiki/connectors/git-repo/raw/2026-08-22T18-13-00-193Z/manifest.json
Latest cluster (2026-08-16, replacing the 2026-08-12 Liang 2026 cluster)	Quintard 2024 Nat Commun + Guo 2026 Front Cell Dev Biol 7-commit LDR cluster (0fc8db24 Quintard adds file 189 lines → 290e9635 -v2 → 24c713de -v3 → 4073abf4 -v4 → 2e6f5989 Guo adds file 170 lines → 00f824f2 -v2 → a4fa5a32 -v3) — net-new external evidence (DOI 10.1038/s41598-026-42990-2, PMID 41857098, mouse liver 3-轨道 Hep-Orgs + Cho-Orgs + HSC + DAPT+Dex P1-P10 长程成熟 + TGFβ 激活体外纤维化模型)
Latest uncommitted artifact (2026-08-13 → 2026-08-22, multi-file, unchanged at the 2026-08-22T18:13Z fetch)	04-Literature/Deep-Reads/Review/zhou2023_computer_vision_microfluidics.md (carry-forward untracked from 2026-08-13, now at 11-day carry-forward at the 2026-08-22 fetch — file mtime 2026-08-11 16:31:54 +0800 so mtime-based carry-forward is 11 days; first-observation-date-based carry-forward is 9 days; structural signal continuing to weaken per /sources/git-repo.md Notable-entity entry — 9 consecutive fetches silent on the file; subfolder is more likely a one-off than a recurring pattern) + 2 new untracked directories added at the 2026-08-17 fetch, still-uncommitted at the 2026-08-22 fetch (6-day carry-forward each — was 5-day at the 2026-08-21 fetch): celvivo_commercial/1331651_20260630_131201.pdf (6-30 quote PDF migrated into new folder) + templates/类器官IRB申请清单.md (180-line IRB application checklist derived from Guo 2026; Robin's first customer-facing template produced from a single deep-read — see the new Templates subtree below)

Vault navigation index (top-level folders)

Dir	Purpose	Size hint
01-Active-Sales/	Active sales pipeline (board + per-account)	6 .md
02-Active-Deals/	Deal-level active docs	1 .md
02-Clients/, 02-Contacts/	Client & contact records	sparse
03-Product/	Product briefs (e.g. 3Brain-Maxwell comparison)	1 .md
03-Resources/Agents/	Distributor / agent profiles	a handful
03-Resources/End-Customers/	End-customer dossiers (3Brain MEA accounts, etc.)	11+ .md
03-Resources/ITX-24h-Host/	Personal 24h Hermes-Agent host build config (2026-07-31 untracked)	1 .md
04-Literature/	Paper deep-reads + curated vendor PDFs	see breakdown below
05-Documents/Contracts/	Signed/pending contracts (Celvivo subfolder)	—
05-Documents/Products/	Vendor-facing product docs (Celvivo/Industrial-Customers)	—
05-Documents/{Proposals,Quotes,Visit-Plans}/	Active commercial docs	—
05-Products/	In-house product briefs (MappingLab family)	2 .md
06-Sales/Competitors/	Competitor tracking	—
06-Sales/Configurations/	Product configurations	—
06-Sales/Content/{FAQ,Pain-Points,PPT-Scripts,Success-Stories,Training-Materials,推文模板}/	Sales content library	—
06-Sales/{Price-List,Product-Mapping,Recommendation-Engine}/	Sales tooling	—
99-Templates/	Reusable Obsidian templates	14 .md
memory/	Daily reports, weekly digests, .dreams, archive	147 .md

04-Literature/Deep-Reads/ breakdown

Subfolder	.md count	Vendor / scope
Organoid/	661 (+2 from 2026-08-16 — Quintard 2024 Nat Commun microfluidic vascularized organoid chip + Guo 2026 Front Cell Dev Biol organoid ethics systematic review)	broad organoid literature
Celvivo/	142	CelVivo vendor + CelVivo-adjacent papers
3Brain/	136	3Brain vendor + 3Brain-adjacent papers
Cellink/	129	Cellink vendor + Cellink-adjacent papers
Organoid-List/	51	curated organoid reading lists
Product-Reports/	38	vendor product reports
Brain/	11	brain organoid focus
Brain-Tumor/	9	brain tumor organoid
Cancer/	6	cancer organoid
Liver/	7	liver organoid / HepG2 (Liang 2026 4-commit LDR cycle 2026-08-12)
Other/	6	uncategorised
RegenMed/	1	Ronawk Bio-Block MSC 4-week (added 2026-07-28)
3Brain MEA/	3	3Brain HD-MEA papers
Cardiac/	2	cardiac organoid
Kidney/	2	kidney organoid
Retinal/	1	retinal organoid
Microbioreactor/	1	Rosero 2026 Front Bioeng Biotechnol (added 2026-08-07)
Cells/	1	Fernandez Vallone 2026 Cells THSDC (added 2026-08-08)
Review/	1	Zhou 2023 computer vision + microfluidics (added 2026-08-13, untracked, 10-day carry-forward at 2026-08-21 fetch (was 9-day at 2026-08-20) — 8 fetches silent — structural signal continuing to weaken; 11-day carry-forward at 2026-08-22 fetch — 9 fetches silent)
Templates/	1	类器官IRB申请清单.md v1.0 (2026-08-16, derived from Guo 2026 ethics deep-read, untracked; first customer-facing template produced from a single deep-read; 5-day carry-forward at 2026-08-21 fetch — was 4-day at 2026-08-20; 6-day carry-forward at 2026-08-22 fetch)
CelVivo-commercial/	1	1331651_20260630_131201.pdf (2026-06-30 quote PDF migrated into new folder 2026-08-17, untracked; 5-day carry-forward at 2026-08-21 fetch — was 4-day at 2026-08-20; 6-day carry-forward at 2026-08-22 fetch)

Total ≈ 1,206 deep-read notes on main + 1 untracked entry in the new Review/ subfolder (zhou2023_computer_vision_microfluidics.md, 2026-08-13 — first review-type subfolder; future-commit candidate) + 2 new untracked directories (templates/类器官IRB申请清单.md + celvivo_commercial/1331651_20260630_131201.pdf, 2026-08-17). The 4 vendor subfolders (Celvivo / 3Brain / Cellink / Organoid) cover the canonical product KB per the wiki goal focus areas. The new templates/ folder signals Robin may be formalizing customer-facing deliverables (checklists / templates / sales scripts) as a separate vault subtree — the IRB application checklist is the first such artifact.

Literature deep-read (LDR) pipeline

The 4-27 SOP (referenced from /sources/ldr-report-template.md and /sources/2026-07-27-4-27-sop-vs-implementation.md) is the canonical research workflow Robin uses to convert a vendor-paper PDF into a publishable, indexed, cross-system deep read.

stateDiagram-v2
    [*] --> PubmedVerify: Id / DOI / PMID / PDF
    PubmedVerify --> PDFPull: PubMed eSummary 验真
    PDFPull --> ImgExtract: ragflow_direct_download.py / direct path
    ImgExtract --> VisionReview: PyMuPDF xref dedup + 30KB + p1 logo
    VisionReview --> ReportWrite: Ollama qwen2.5vl:7b (降级 if 服务宕)
    ReportWrite --> SeaFileUpload: 5 段模板 (做了什么 / 3 发现 / 4 维对接 / 局限 / 转发语)
    SeaFileUpload --> WikiPublish: PDF + 3 真图 → ?dl=1
    WikiPublish --> NocoDB: GraphQL 5-orderBy union
    NocoDB --> Commit: NocoDB v1 + JSON body (PATCH preferred)
    Commit --> [*]: OpenWiki git commit + Gitea push
    note right of VisionReview
      2026-07-17 起 Ollama 服务宕
      视觉审核降级 → 人工肉眼
    end note
    note right of NocoDB
      Cellink 库 "已精读" SingleSelect options=[]
      PATCH 失败, 在精读摘要里写
    end note

The state diagram shows the canonical LDR pipeline: PDF → images → report → SeaFile → Wiki.js → NocoDB → commit. Two known operational degradations are called out: the Ollama visual-review step falls back to human review since 2026-07-17 (see /themes/04-local-llm.md), and the Cellink library 已精读 SingleSelect is a NocoDB bug that blocks PATCH (workaround documented in the SOP-vs-implementation file).

LDR SOP — 8 铁律 + 3 trigger modes + 5-section report

From /sources/ldr-report-template.md (Robin 7-27 实战版):

铁律	出处	实操
1. PDF 全文必传 (SeaFile 永久链接, ?dl=1 后缀)	7-27 教训	upload.py 上传 PDF, ?dl=1 写 link
2. PyMuPDF xref 去重 + 30KB 过滤 + p1 logo 剔除	7-27 教训 (Tasevska p1 logo)	extract_image(xref) per page, MD5 dedup
3. 9 项强制 + 创新点/局限性/学术启示 3 段	7-27 教训 (2 篇缺 3 段)	模板 §3
4. SeaFile URL hostname fb.biokingdom.top	7-27 教训 (5 URL 错)	验证 share-link 真能开
5. NocoDB v1 + JSON body (范本 v2 失败 3 次)	7-27 Tasevska 入库	POST /api/v1/db/data/wzg1wtad/p2z4g0s687axyvu/{table_id}
6. 3 张真图 ![]() (SeaFile URL), 不只文字图说啥	7-27 教训	markdown image syntax (alt text + parenthesized URL)
7. 报告路径 journal-year-topic (4-27 SOP 范本)	7-27 教训	ejps-2025-hctz-sse-3d-printing 风格
8. 精简 4 步 vs 完整 8 步按 Robin 信号自动判断	7-27 实战	模板 §2

3 trigger modes:

Robin says	I take	耗时
"精读吧" (any PDF, no publish intent)	精简 4 步 (PDF → PyMuPDF → 写报告 → Obsidian)	20-30 min
"A" / "发 wikijs" / "SeaFile 永久" / "入库" / "NocoDB"	完整 8 步 (精简 4 步 + Ollama 视觉 + SeaFile + Wiki.js + NocoDB)	45-60 min
"X 还是 Y" / "你定" / "继续下一篇"	自动	—

5-section report template (800–1500 chars): 1. 做了什么 / 2. 3 关键发现 (每发现 3 段式表) / 3. 4 维产品对接 (CelVivo / 3Brain / Cellink / Femtobiomed) / 4. 局限 / 5. 转发语 + 落款 + PDF.

Worked examples (canonical deep reads)

Deep read	Vendor	Path	Synthesized at
Bosnjakovic 2025 bioRxiv	CelVivo	04-Literature/Deep-Reads/Celvivo/Bosnjakovic_2025_PAH_3D_spheroid_CelVivo_ClinoStar_2026-07-27.md	/sources/literature-cel-bosnjakovic-2025-pah-deepread.md
Raji 2026 Mol Psychiatry	3Brain	04-Literature/Deep-Reads/3Brain/Raji_2026_hMOs_dopaminergic_3Brain_MEA_2026-07-27.md	/sources/literature-raji-2026-deepread.md
Tasevska 2025 EJPS	Cellink	04-Literature/Deep-Reads/Cellink/Tasevska_2025_HCTZ_3D_printed_extended_release_2026-07-27.md	/sources/literature-tasevska-2025-deepread.md
CelVivo 2026 brain organoid whitepaper (16 pp)	CelVivo	under 04-Literature/Deep-Reads/Celvivo/	/sources/literature-celvivo-brain-whitepaper-2026.md
Hodge 2025 RegenMed	Ronawk Bio-Block (KB 0 命中)	04-Literature/Deep-Reads/RegenMed/2026-07-28_Hodge_2025_RegenMed_MSC_3D_Bio-Block.md	(not yet synthesized to /sources/)
Lee 2025 Front Vet Sci	(no vendor)	04-Literature/Deep-Reads/Other/2026-07-28_Lee_2025_FrontVetSci_canine_MSC_3D_spheroid.md	(not yet synthesized)
Parate 2020 SCRT	(no vendor)	04-Literature/Deep-Reads/Other/2026-07-28_Parate_2020_SCRT_PEMF_MSC_paracrine_cartilage.md	(not yet synthesized)
Sharma 2026 Cell Stem Cell (2026-08-08 flywheel-sync)	3Brain + CelVivo adjacent	/home/ldw/workspace/retinal_organoid_deep_read_2026-08-07.md	/sources/literature-sharma-2026-cell-stem-cell-vascularized-retinal-organoid-rgc-deepread.md
Miao 2025 Cell v2 (2026-08-08 flywheel-sync)	CelVivo (ClinoStar rating 5)	/home/ldw/workspace/Miao2025_Cell_v2.md	/sources/literature-miao-2025-cell-vascularization-v2-deepread.md
Liu 2026 Nat Biomed Eng (2026-08-08 flywheel-sync)	3Brain (HD-MEA rating 5) + Cellink (microlattice rating 5)	/home/ldw/workspace/Liu2026_NBME_shape_conformal_organoid.md	/sources/literature-liu-2026-nbme-shape-conformal-organoid-deepread.md
Quintard 2024 Nat Commun (2026-08-16 vault LDR cluster)	CelVivo (ClinoStar rating 3 upstream) + Mimetas OrganoPlate (rating 4 direct) + Emulate Organ-Chip (rating 3)	obsidian-vault/Literature/Deep-Reads/Organoid/quintard_2024_vasorganoid_chip.md	(not yet synthesized to /sources/)
Guo 2026 Front Cell Dev Biol (2026-08-16 vault LDR cluster)	CelVivo (ClinoStar rating 4 clinical-translation IRB) + Mimetas OrganoPlate (rating 4 co-culture ethics) + Emulate Organ-Chip (rating 3)	obsidian-vault/Literature/Deep-Reads/Organoid/guo_2026_organoid_ethical_review.md	(not yet synthesized to /sources/; derived customer-facing template at templates/类器官IRB申请清单.md v1.0)

Recent 30-day research output (mtime 2026-06-16 → 2026-08-12)

From /sources/literature.md last sync, broken out by vendor and date:

Date	DOI / slug	Vendor	Topic
2026-08-16	Quintard 2024 Nat Commun + Guo 2026 Front Cell Dev Biol 7-commit LDR cluster (commits 0fc8db24 + 290e9635 + 24c713de + 4073abf4 Quintard + 2e6f5989 + 00f824f2 + a4fa5a32 Guo)	CelVivo adjacent + Mimetas OrganoPlate ⭐⭐⭐⭐ + Emulate Organ-Chip ⭐⭐⭐ (Quintard) / CelVivo ClinoStar ⭐⭐⭐⭐ + Mimetas OrganoPlate ⭐⭐⭐⭐ + Emulate Organ-Chip ⭐⭐⭐ (Guo)	Quintard C et al. (2024) A microfluidic platform integrating functional vascularized organoids-on-chip (Nat Commun DOI 10.1038/s41467-024-45710-4, Wiki ID 1719/1720/1722, NocoDB Id 3297; 10 通道并行微流控 + hiPSC-BVO 30 天功能性灌注培养 + 跨类器官验证 [间充质球体 / BVO / 胰岛球体 / 肺类器官]; 血管层级化 37 µm 上游动脉-静脉 + 8 µm BVO 毛细管, 壁剪切 27-2000 s⁻¹, 完美匹配人体毛细血管生理范围 50-1900 s⁻¹) + Guo Z & Zhang N (2026) Ethical review key considerations for organoid applications in biomedical research—a systematic review (Front Cell Dev Biol DOI 10.3389/fcell.2026.1721946, Wiki ID 1724, NocoDB Id 3298; 嘉兴市第一医院 + 嘉兴大学医学院视角; 类器官研究 IRB / 伦理审查 7 大强制要点系统综述 [样本来源/知情同意/数据隐私/共培养主体性/3R 动物福利/跨境监管/长期保存与终止使用] + 中国《人类遗传资源管理条例》+ 国际 ISSCR/GDPR/HIPAA 多国对照表). Robin translated Guo 2026 into a customer-facing IRB application checklist template (templates/类器官IRB申请清单.md v1.0 180 lines) — first customer-facing template produced from a single deep-read.
2026-08-12	Liang 2026 liver organoid fibrosis platform 4-commit LDR cycle (commits e542c977 + 8699a154 + aacba7aa + 297f106d)	CelVivo (ClinoStar rating 5 + ClinoReactor rating 5)	Liang Y et al. (2026) A robust mouse liver organoid platform enables sustained multicellular maturation and fibrosis modeling from a single tissue sample (Sci Rep DOI 10.1038/s41598-026-42990-2, PMID 41857098; Wiki.js Id 1716, NocoDB Id 770; 3 轨道 Hep-Orgs + Cho-Orgs + HSC 同步分离; DAPT+Dex P1-P10 长程稳定成熟 [ALB/PAS/LDL/CYP 跨代保持]; TGFβ 激活 qHSC → aHSC [Acta2/Col1a1 上调]; aHSC 共培养诱导 Hep-Orgs EMT [Snail/Twist/Vimentin↑; ALB/CK8↓; Lgr5/EpCAM↓; Ki67↓] = 体外肝纤维化模型) — page 946 9 项 SOP 重写版 + page 934 修齐 标杆; 7/7 Ollama qwen2.5vl 视觉审核通过; SeaFile 7/7 公网 200 验真. First paper whose related: field already names [[MOC-类器官与3D培养]] (the 2026-08-10 first MOC) on the day of publication.
2026-08-10	Phase A metadata batch + first MOC (commits d97b39ed + 6b717aef + 3b929c2f)	(process discipline)	6 deep-reads received the 6-field frontmatter (doi/journal/year/volume/pages/authors/pmid); first MOC MOC-类器官与3D培养.md (95 lines, 沙牛《AI 时代的 Obsidian 公开课》课时 1 pattern) created at 04-Literature/Deep-Reads/MOCs/; 7 image alt descriptions added on wang2024-org-on-chip.md. No new external evidence.
2026-08-09	10.7150/thno.90492 (Wang 2024)	(4 类共性硬件 — Organoid-on-Chip 综述)	Wang H et al. (2024) Human organoids-on-chips for biomedical research and applications (Theranostics 14(2):788-818, PMID 38169573; 7 图覆盖 7 大主题板块) — Wiki.js ID 1700 (v2 - grp:3 ghost page 累加)
2026-08-08	10.3390/cells15110963 (Fernandez Vallone 2026)	(NAMs adjacent, hiPSC brain organoid)	THSDC chemical evaluation platform using hiPSC brain organoids (Cells, v2 5 张真图 + 双 H1; Wiki.js Id 1698)
2026-08-08	10.3389/fbioe.2026.1854988 (Rosero 2026)	CelVivo + Cellink + FemtoBiomed adjacent	Microbioreactor design Mini Review (Front Bioeng Biotechnol; 6× productivity vs T-flask; 4 applications: CAR-T / mAb / iPSC / organoid)
2026-08-08	10.1038/s41551-026-01620-y (Liu 2026)	3Brain (HD-MEA rating 5) + Cellink (microlattice rating 5)	Shape-conformal porous framework for full-coverage neural organoid e-phys — Rogers Lab, Nat Biomed Eng
2026-08-08	10.1016/j.cell.2025.05.041 (Miao 2025 v2)	CelVivo (ClinoStar rating 5)	Co-development mesoderm+endoderm for vascularized lung/gut organoids (Cell v2)
2026-08-08	10.1016/j.stem.2025.12.013 (Sharma 2026)	3Brain (HD-MEA rating 4) + CelVivo (ClinoStar rating 3)	Vascularized retinal organoid RGC survival (Cell Stem Cell)
2026-08-06	10.1038/s41467-024-44732-2 (Parfitt 2024)	CelVivo + 3Brain adjacent	DJ1 LOF midbrain organoid PD model — α-syn via astrocyte lysosomal degradation (Nat Commun, untracked)
2026-07-29	Organoids for disease modeling and treatment 2026 综述 (PMID 41545895, PMC12828948)	review	Exp Hematol Oncol 2026 — 190 项临床试验 + 4 大瓶颈
2026-07-28	10.1080_17460751.2025.2572177 (Hodge 2025)	Ronawk Bio-Block	MSC longevity 4-week comparison
2026-07-28	10.3389/fvets.2025.1500267 (Lee 2025)	(no vendor)	canine adipose MSC 3D spheroid
2026-07-28	10.1186_s13287-018-1085-9 (Komatsu 2018)	CelVivo + Cellink	Type I collagen + YAP/TAZ
2026-07-28	10.1186_s13287-020-1566-5 (Parate 2020)	(no vendor)	PEMF potentiate MSC paracrine cartilage
2026-07-27	Raji_2026_hMOs	3Brain	hMOs dopaminergic + HD-MEA
2026-07-27	Tasevska_2025_HCTZ	Cellink	SSE-printed HCTZ extended-release
2026-07-17	260528_CS_vs_OS appnote	CelVivo	ClinoStar vs Orbital Shaker shear stress
2026-07-17	111_Planimetry appnote	CelVivo	FIJI planimetry on ClinoReactor
2026-07-05	10.1002_btpr.2528	CelVivo	Spheroid dissociation device
2026-06-25	10.1016_j.stemcr.2025.102646	CelVivo	High-throughput microfluidic organoid-on-a-chip
2026-06-24	10.1021_acsomega.5c02682	3Brain	rotating human melanoma cell culture
2026-06-24	10.1016_j.xpro.2025.103923	CelVivo	Lung Tumoroids protocol
2026-06-23	10.1002_jbm4.10792	CelVivo	microfluidic organoid-on-a-chip (v2-munir2023)
2026-06-23	10.3390_cells11203216	CelVivo	NAFLD mapping proteome/lipidome

By vendor (30-day mtime):

Vendor	Most recent	2026-08-08 / 2026-08-10 / 2026-08-12 / 2026-08-16 additions
CelVivo	2026-08-12 (Liang 2026 — ClinoStar rating 5 + ClinoReactor rating 5)	+Liang 2026 (P1-P10 长程成熟 + 单组织 3 轨道分通道灌流 + TGFβ 时间程序精确切换 — liver organoid fibrosis platform), +Miao 2025 v2 (ClinoStar co-differentiation), +Sharma 2026 (ClinoStar rating 3 adjacent), +Liu 2026 (ClinoStar rating 4 adjacent), +Quintard 2024 (CelVivo ClinoStar rating 3 — upstream workflow step: BVO day 0-15 needs rotating-wall suspension culture), +Guo 2026 (CelVivo ClinoStar rating 4 — clinical-translation IRB compliance for 三甲医院 客户)
3Brain	2026-08-08 (Liu 2026 — HD-MEA rating 5)	+Liu 2026 (shape-conformal framework, next-gen HD-MEA), +Sharma 2026 (HD-MEA rating 4 adjacent), +Shin 2024 (Phase A frontmatter hygiene on existing note), −3Brain reference removed from Quintard 2024 -v4 (per commit 4073abf4 — "精读 Quintard 2024 -v4 (转发语标题/落款加粗/删3Brain)" was the explicit SOP rule "硬门槛合规修正" cleanup; Quintard is vendor-adjacent CelVivo/Mimetas/Emulate rather than 3Brain territory)
Cellink	2026-07-27 (Tasevska 2025)	+Liu 2026 (microlattice fabrication rating 5 adjacent), +Quintard 2024 (microfluidic organ-on-chip adjacent, no direct Cellink rating — but the platform architecture is a candidate cross-sell with Cellink BIO X for vascularized scaffold fabrication)
Adjacent (no vendor)	2026-08-08 (Sharma 2026 retinal vascularization)	+Sharma 2026 (retinal organoid application domain)
(Process discipline)	2026-08-10 (Phase A batch + first MOC)	+6 deep-reads received 6-field frontmatter; +first MOC MOC-类器官与3D培养.md created; +7 image alt descriptions on Wang 2024 — no new external evidence
(Subfolder expansion, uncommitted)	2026-08-13 (new Review/ subfolder)	+1 untracked file Review/zhou2023_computer_vision_microfluidics.md (first review-type subfolder — review papers stream separately from original research)
(Customer-facing template, uncommitted)	2026-08-16 (new templates/ subfolder + IRB application checklist v1.0)	+1 untracked file templates/类器官IRB申请清单.md 180 lines (Guo 2026 ethics deep-read → IRB checklist template; 7 mandatory points + 5 customer Q&A + China vs International flow + 10 attachments + 7 citations; Robin's first customer-facing template produced from a single deep-read; will route into CelVivo industrial-customers program once committed)
(Commercial quote PDF, untracked)	2026-08-17 (new celvivo_commercial/ subfolder)	+1 untracked file celvivo_commercial/1331651_20260630_131201.pdf (6-30 quote PDF migrated into a new folder; companion to the existing 05-Documents/Products/Celvivo/Industrial-Customers/ commercial-docs subtree)

The pipeline is vendor-balanced — CelVivo, 3Brain, Cellink each have a recent deep read, and the 2026-08-08 flywheel-sync adds 3 papers spanning all 3 primary vendors + the retinal organoid application domain (Sharma), all 3 rated 4-5 on at least one vendor's product line. The 2026-08-10 cluster is process discipline (Phase A metadata batch + first MOC creation + Wang 2024 alt-description sample), not new external evidence — the 6 deep-reads already existed on main; the 3 commits only normalize their metadata and add a knowledge-graph index layer. The 2026-08-12 cluster adds net-new external evidence: Liang 2026 Sci Rep liver organoid fibrosis platform (4-commit LDR cycle on a single paper, CelVivo ClinoStar ⭐⭐⭐⭐ + ClinoReactor ⭐⭐⭐⭐); this is the first paper on main whose related: field already names [[MOC-类器官与3D培养]] on the day of publication, confirming the MOC pattern is in active use on real deep-reads (vs the prior 2026-08-10 "MOC related: lists future MOCs" framing which was only prospective). The first entry in the new NocoDB table Robin_Picked_Papers is Liu 2026 (created 2026-08-08 per Robin instruction to capture papers Robin hand-picks / provides outside the regular PubMed triage). The first MOC MOC-类器官与3D培养.md is the start of a Map-of-Content layer Robin appears to be building (the MOC's own related: already names [[MOC-3Brain-HD-MEA]] as the next planned MOC). The 2026-08-13 cluster (no vault commits, 1 new untracked file) adds a new Review/ subfolder to the deep-read tree — Robin appears to be expanding the folder taxonomy to separate review-type papers from original-research papers; whether this is a one-off subfolder or the start of a recurring folder pattern is a watchlist item for the next git-repo fetch. The 2026-08-16 cluster (Quintard 2024 + Guo 2026) is the largest single-window vault delta since the 2026-07-28 / 2026-07-29 cluster — 7 new vault commits spanning 2 new paper deep-reads, 2 new untracked working-tree directories, and 1 customer-facing sales-ammunition template derived from a single deep-read. The Quintard 2024 microfluidic / organ-on-chip platform (CelVivo ClinoStar upstream + Mimetas OrganoPlate direct competitor + Emulate Organ-Chip) extends Robin's vendor mapping into the organ-on-chip product lane that his portfolio doesn't currently cover; the Guo 2026 organoid ethics systematic review (7 mandatory points + 5 jurisdiction comparison) introduces the IRB / ethics domain to Robin's deep-read set and spawned templates/类器官IRB申请清单.md (180 lines, Robin's first customer-facing template) as the canonical "Robin 培训客户 IRB 申请" core material. The new templates/ + celvivo_commercial/ directories appear alongside the existing 05-Documents/Products/Celvivo/Industrial-Customers/ commercial-docs subtree — Robin may be formalizing customer-facing deliverables (checklists / templates / sales scripts) as a separate vault subtree. The Review/zhou2023_computer_vision_microfluidics.md carry-forward untracked file is still-uncommitted at this fetch (now 4 days past the 2026-08-13 first observation); the watchlist trigger is if it remains uncommitted at the next fetch.

Sales ammunition pipeline

Robin maintains a working sales library that consumes LDR output and routes into the /sources/sales-ammunition.md page:

• Pricing + SKUs: Demo kit 10005-6 lists at €300 (Global Distributor Price, with special discount); 10004-12 ClinoReactor 12-pack; 30003 ClinoStar; SP5D-24W low-adherence plate. Pricing source: Exhibit 1_Celvivo Price Book 2026_Global_Distributior.xlsx (RAGFlow KB full-text).
• 8 ClinoReactor Protocols: 003 (prepare) / 004 (media change) / 006 (gardening) / 009 (plate config) / 010 (ClinoReactor prepare) / 012 (rotation speed — core selling point) / 014 (alginate embed) / 015 (VitroGel embed).
• 5 application notes by organ: HepG2/C3A liver / FTC-133 thyroid / NCI-H69V SCLC / TNBC / ClinoStar vs Orbital Shaker.
• 5 brand / whitepapers: Brochure 2026 update_for print + _online version / Cancer White Paper 2026 / 2026.04.01.715868v1 (biorxiv 2026 preprint) / ijms-24-13506-v2.
• 8 commercial docs: Exhibit 1 Price Book / Exhibit 3 SuperUser certification / Huibai demo discount agreement / 惠百 PO 盖章版 / Celvivo Distribution Agreement 2026 Huibai Bio / 1331651_20260630_131201 (6-30 quote) / Packing Slip Ordre 726_1 / Packing Slip Ordre 726_2.

Cross-link to the canonical synthesis: /sources/sales-ammunition.md.

2026-08-16 addition — templates/类器官IRB申请清单.md v1.0 (180 lines, Robin 8-16 实战沉淀, untracked; derived from Guo 2026 Front Cell Dev Biol IRB / ethics systematic review — Wiki.js ID 1724, NocoDB Id 3298). The IRB application checklist is Robin 第一份 customer-facing template produced from a single deep-read and consists of: (a) 7 强制要点 [样本来源合法性 + 捐赠者知情同意 + 数据隐私与去标识化 + 共培养产物主体性评估 + 动物福利 3R + 跨境监管合规 + 长期保存与终止使用]; (b) 5 customer Q&A [类器官研究是否要 IRB 申请 / 类器官共培养产品怎么申请 IRB / 类器官跨境研究怎么报 / 3R 原则怎么写 / 类器官 + 免疫细胞共培养 = CAR-T 体外培养, 算不算新生物体]; (c) China vs International flow comparison table [中国 2023 新规 vs 美国 Common Rule vs 欧盟 GDPR]; (d) 10 申请附件清单 [IRB 申请表 + 知情同意书 + 研究方案 + DMP + 样本采集机构 IRB 批件 + ...]; (e) 7 引用 [Guo 2026 + ISSCR 2021 + OHRP 2016 + GDPR + 中国 2023 + 中国 2019 + Cambridge 2020]. Vendor relevance: CelVivo ClinoStar ⭐⭐⭐⭐ (the 7 mandatory points directly apply to ClinoStar customer IRB submissions; Robin 推广 ClinoStar 给三甲医院时, 可附带本框架作为增值). Tracks as /commitments.md guo-2026-organoid-irb-checklist-rollout (Owner: me; fold IRB application checklist into CelVivo industrial-customers program + Robin customer-training core material; commit templates/类器官IRB申请清单.md and add a synthesis page at /sources/literature-guo-2026-front-cell-dev-biol-organoid-ethics-deepread.md).

Sales training cluster (working-tree additions)

Per /sources/git-repo.md §"Notable entities", 06-Sales/Content/Training-Materials/ contains the following working-tree additions not yet on main:

• CelVivo_销售培训_PPT_v9_给销售看版.pptx (3.9 MB, 06-26 14:13) — latest PPT
• CelVivo_Robin老师逐字稿_v6_深度版_20260626.md (63 KB, 06-26 13:45) — latest verbatim script
• CelVivo_销售培训_讲义_v2_20260626.md (13 KB, 06-26 12:14) — latest handout
• Robin稿生成通字稿 family (v3–v6) and CelVivo赋能培训 family (v1–v9, depth-flavored edits)
• 销售基础话术包 pair

The version progression is 基础 → 5大管线 → 深度版 → 终稿修正 → 销量仅看 — the cluster is iterated in place, not committed. See /sources/vault-mtime-snapshot-2026-07-16.md for the latest mtime census (CelVivo_销售培训_PPT_v9 = 2026-06-26 14:13).

China distributor map (259 dealers across 7 regions — 2026-08-07 baseline)

From /sources/distributors-china-2026.md (Hermes整理, 2026-08-07; replaces 2026-07-24 baseline of 261 dealers):

Region	8-07 count	7-24 count	Δ	Share	Main city
华北	72	74	-2	27.8%	北京 (54)
华东	68	68	0	26.3%	上海 (53)
华南	62	62	0	23.9%	广州 (44)
山东	25	25	0	9.7%	济南 (22)
湖北	19	19	0	7.3%	武汉 (12)
西北	6	6	0	2.3%	西安 (6)
西南	7	7	0	2.7%	重庆 (3)
TOTAL	259	261	-2	100%	—

Brand keyword map (top 20 by 全国 count): BI 19 / Thermo 19 / Bio-Rad 11 / 赛默飞 8 / 安捷伦 7 / 蔡司 6 / Cytiva 6 / 伯乐 6 / 徕卡 6 / 赛多利斯 5 / Eppendorf 5 / Leica 5 / Beckman 4 / Merck 4 / Waters 4 / Azure 3 / Bruker 3 / Oxford Nanopore 3 / Agilent 3 / Sartorius 3.

8-07 独有产品-代理映射 (from _known_associations.md):

产品线	关联代理 / 中间方	关联客户 / 商机
CelVivo (ClinoStar)	济南成全生物科技 (曹沛起) — 华北 + 山东 跨区重复	董慧群 (CelVivo 技术同事) — 8-07 hook 4 候选
FemtoBiomed (CellShot / PROLIVA)	9X Bio (汇佰生物) — 中间方 (0 hit in 259 dealer 表)	TriArm Therapeutics (翁靖傑 上海 CGT/CAR-T, 128 万 Phase1 / 8-10 至 8-14 现场 demo)
3Brain (HD-MEA)	0 家代理命中	11+ end-customer dossiers (需要补 direct agent or sell direct)
Cellink (BIO X)	0 家代理命中	(待补)

Data gap (regional filling rate): 华东 营收 0/68 / 湖北 营收 0/19 / 华南 销售人数 0/62 — needs补 before next field visit. Documented at /sources/distributors-china-2026.md §关键数据缺口.

4-vendor break-out is partially resolved: the 2026-08-07 _known_associations.md index identifies CelVivo → 济南成全 + FemtoBiomed → 9X Bio; 3Brain / Cellink direct agents are still 0 (open-question distributors-3brain-cellink-zero-coverage).

CRM — active distributor profiles

From /sources/agents.md (last sync 2026-07-28; 2026-08-07 _known_associations.md partial resolution):

姓名	角色	代理商品牌	主推产品	首次记录	状态	Vault 路径
董慧群	代理商技术同事	待补	CelVivo (ClinoStar / ClinoReactor)	2026-07-28	active	02-Clients/Agents/董慧群.md

This is the only profile currently in the agents bucket. Robin was told about 董慧群 via WeChat DM on 2026-07-28; her role is to help push CelVivo products at the technical / demo / selection stage. Most fields are 待补 (agency name, region, phone, WeChat, customers, opportunities) — this is the only active open question in /open-questions.md (see agent-dong-huiqun-celvivo).

2026-08-07 partial resolution (Hermes hook 4): 4 个经销商管理 Hook 升级 (02-Clients/Agents/_known_associations.md commit 4b237a82) identifies 济南成全生物科技有限公司 (曹沛起) as the only CelVivo ClinoStar-listed agent in the 259-dealer China map (华北 + 山东 跨区重复登记). Whether 董慧群 is 济南成全的技术同事 or another dealer is still unverified — tracked as commitment dong-huiqun-ji-nan-chengquan-link in /commitments.md. The same hook 4 file maps FemtoBiomed CellShot → 9X Bio (汇佰生物) → TriArm Therapeutics (翁靖傑 上海 CGT/CAR-T, 128 万 Phase1 / 8-10 至 8-14 现场 demo), and 3Brain / Cellink / FemtoBiomed direct agents → 0 in the 259 baseline (open-question distributors-3brain-cellink-zero-coverage).

Privacy rule (Robin 7-28): /sources/agents.md and /sources/distributors-china-2026.md contain only base identity (name / role / vendor / region); sensitive fields (phone / WeChat / email / end-customer list / opportunity value) live only in the private Obsidian vault. The 2026-08-07 _known_associations.md index adds the product-line → agent → end-customer → opportunity mapping chain — but does not break the privacy rule because sensitive fields remain in the private vault files.

End-customer dossier set

11+ dossiers under 03-Resources/End-Customers/ covering 3Brain HD-MEA accounts at: 神经所 (上海), 北京大学, 北京天坛医院, 浙大一附院, 中科院昆明动物所, 西南医科大学, 贵州医科大学, plus TCM accounts at 云南中医药大学 and 天津创新中药. Dossier content lives in the private vault — only the vault paths are surfaced to the wiki. Documented at /sources/git-repo.md §Notable entities.

CelVivo industrial-customers program (China commercial)

A dedicated subfolder under 05-Documents/Products/Celvivo/Industrial-Customers/ holds:

• CelVivo_中国工业客户开发研究报告 (v1 + v2)
• 客户管线定位_1页图
• 工业客户开发手册-v3

This is a self-contained CelVivo China commercial effort. The latest mtime census (2026-07-16 snapshot) shows CelVivo_中国工业客户开发研究报告_20260626_v2.md as the most-recent file (18 KB, 06-26 11:52). Documented at /sources/git-repo.md §Notable entities.

2026-08-17 working-tree addition — celvivo_commercial/1331651_20260630_131201.pdf (56 KB, 2026-06-30 quote PDF migrated into a new folder; untracked) — companion to the existing 05-Documents/Products/Celvivo/Industrial-Customers/ commercial-docs subtree. The new folder name signals Robin may be consolidating "Celvivo commercial" documents into a separate vault subtree rather than continuing to nest them under 05-Documents/Products/Celvivo/Industrial-Customers/ (which is the prior convention). If the convention holds, future CelVivo commercial PDFs / quotes / pricing tables will land in celvivo_commercial/ instead of 05-Documents/Products/Celvivo/Industrial-Customers/; if it doesn't hold, it's a one-off folder for the 6-30 quote. Watchlist trigger: if a second PDF or commercial doc lands in celvivo_commercial/ by the next git-repo fetch, the convention change is real; if it stays single-entry, it's a one-off.

Work-rhythm snapshot (2026-07-16)

From /sources/vault-mtime-snapshot-2026-07-16.md (last full mtime census):

2026-07-05  CelVivo 文献精读最后一次 (1 篇)
2026-06-26  销售培训物料最后一次更新 (v9 PPT + 逐字稿)
2026-06-18  memory/ 最后一次 daily report
2026-06-09  vault commit 最后一次
2026-06-06  CelVivo protocol 系列入库最后一次
2026-06-04  weekly report 最后一次

Conclusion (snapshot date): Past 3 weeks (post 2026-07-05) had 0 CelVivo activity. This is real state, not an OpenWiki gap. The snapshot recommends Robin write a memory/2026-07-16-*.md daily report to capture the gap. This also means the OpenWiki cron vault-mtime-snapshot connector is the canonical work-rhythm evidence — it complements the git-repo connector (commit history) and NocoDB (last-touched metadata).

Cross-vendor route map

Each research output eventually lands in one of the vendor synthesis themes:

Research artifact	Primary route	Secondary
CelVivo deep reads + sales ammunition	/themes/01-organoid-equipment.md	CelVivo industrial-customers program → /commitments.md
3Brain deep reads + end-customer dossiers	/themes/01-organoid-equipment.md	3Brain conference positioning → /commitments.md 3brain-coreplate-2026-conference-positioning
Cellink deep reads + BIO X customer evidence	/themes/02-bioprinting.md	New Lumen X release → /commitments.md cellink-volumetric-lumen-x-release
Femtobiomed deep reads + CellShot-TriArm demo plans	(theme gap — Femtobiomed has no synthesis theme yet)	01-Active-Sales/ plans → /commitments.md
Adjacent non-vendor (MSC / canine / PEMF / 综述)	class-organoid-3d-bioprinting theme row on /themes.md	—
China regulatory (CDE / Order 818 / CGT)	/commitments.md items china-cde-cell-gene-therapy-rules-2026 / china-order-no-818-clinical-translation / china-cgt-2026-july-developments	—
Distributor / agent	/sources/distributors-china-2026.md + /sources/agents.md + /open-questions.md agent-dong-huiqun-celvivo	—

Personal-infra and adjacent work

These are source-anchored but not vendor-anchored — they live here for traceability but do not earn a /themes.md row:

• ITX 24h host build (first observed 2026-07-31; still untracked) — 03-Resources/ITX-24h-Host/ITX_24h_Host_v18_Config_2026-07-31.md. Plan: mATX + i5-12400 + DDR4-2666 32G + 板载 Realtek 1Gb + Intel PRO/1000 GT 双网卡 NAS 隔离. Budget ¥2,985.82, 10/11 parts arrived. Status: paused awaiting last #8/#9 cable parts. Tracked as /commitments.md itx-24h-host-build-2026-q3 (Owner: me).
• OpenWiki cheat sheet (2026-07-27) — OpenWiki速查手册_2026-07-27.md (vault root, untracked). Companion to /sources/OpenWiki速查手册.md (the wiki copy).
• 4 vendor + 4 application + 4 agents SOP iterations — the cluster of training materials under 06-Sales/Content/Training-Materials/ is iterated in place without commits; latest is CelVivo_销售培训_PPT_v9 (06-26 14:13).

Cross-cutting relationship

• Touched by /themes/03-ai-agents.md — M3 agent synthesis step (02:00 cron) writes research evidence into the synthesis themes; literature-deep-read SOP is what produces the canonical deep-read pages; sales-ammunition query skill routes ClinoReactor-related questions.
• Touched by /themes/04-local-llm.md — RAGFlow KB (Celvivo / 3Brian / Cellink) is the deep retrieval surface behind every vendor deep read; SeaFile is the PDF + figure storage; NocoDB is the metadata catalog; Wiki.js is the public publishing target. The 2026-07-17 desktop service-down incident materially degrades the LDR pipeline.
• Output routes into /themes/01-organoid-equipment.md and /themes/02-bioprinting.md — most of the deep reads and vendor evidence in this theme ends up at the vendor synthesis themes.
• Outputs routed into /commitments.md — China regulatory items + vendor-channel verification items + ITX host build + CellShot-TriArm demo plans.
• Outputs routed into /open-questions.md — agent-dong-huiqun-celvivo is the only currently active entry; it is anchored to 02-Clients/Agents/董慧群.md and is the kind of "ambiguous people/org relationship" gap the wiki brief calls out.

Backlog for this theme

• Femtobiomed synthesis page — Femtobiomed CellShot / CellPick / TriArm has a vault bucket and a FemtoBiomed_electroporation RAGFlow KB (123 docs) but no synthesis theme. Currently routes as adjacent cross-sell into 01 and 02. Consider promoting to themes/06-femtobiomed.md if vendor-channel evidence accrues.
• Hodge / Lee / Parate synthesis — 3 adjacent deep reads added 2026-07-28 are not yet synthesized to /sources/. Run LDR Step 8 (NocoDB PATCH + Wiki.js publish + OpenWiki commit) when ready.
• Work-rhythm snapshot connector — currently a one-shot find -mtime shell command (see /sources/vault-mtime-snapshot-2026-07-16.md header). Promote to a weekly cron + auto-write to /sources/vault-mtime-snapshot-weekly.md so the work-rhythm signal is durable, not single-snapshot.
• End-customer dossier cross-agent page — 11+ dossiers live in private vault; consider adding a redacted [name, focus, vendor, region, vault-path] table to /sources/agents.md parallel to the distributor profile pattern. Robin decision pending.
• CellShot-TriArm demo plan v3 — current demo plans are v1 (2026-07-21) and v2 (2026-07-22, 邮件用 + 老师版 two-commit split). No v3 yet; the v2 plan lives in vault commit history 1787702c / 62877d1f / 62d09c5f. Promote to /commitments.md when v3 lands.
• MOC pattern extension (2026-08-10 onward) — Robin created the first MOC (04-Literature/Deep-Reads/MOCs/MOC-类器官与3D培养.md, commit 6b717aef, 95 lines, 沙牛《AI 时代的 Obsidian 公开课》课时 1 pattern); the MOC's related: list already names the next planned MOC — [[MOC-3Brain-HD-MEA]] — plus [[02-Clients/Agents/_known_associations]] and [[02-Active-Deals/CellShot-TriArm-Demo-计划-v2-老师版-2026-07-20]]. Track on the next git-repo fetch whether the MOC pattern extends to MOC-3Brain-HD-MEA, MOC-Cellink-BIO-X, MOC-Femtobiomed-CellShot, etc. If ≥3 MOCs land, consider adding a /themes.md annex row on vault-knowledge-architecture and a /sources/ page that maps the MOC graph (file → topics → cross-refs → flywheel cron hooks).
• Phase A frontmatter batch rollout (2026-08-10 onward) — Phase A standardized 6 deep-read notes with the 6-field frontmatter (doi / journal / year / volume / pages / authors / pmid); ~1,196 deep-read notes remain without the new fields. Track rollout cadence — if Robin completes the batch on a fixed cadence (e.g. daily/weekly cron), document the cadence here so future agents can answer "what is the frontmatter hygiene status of the vault?".

What to read next

Question	Go to
What is the canonical LDR master template?	/sources/ldr-report-template.md
What did the 7-27 SOP-vs-implementation pass reveal?	/sources/2026-07-27-4-27-sop-vs-implementation.md
What is the current Obsidian vault manifest?	/sources/git-repo.md
What is the 30-day literature deep-read digest?	/sources/literature.md
What is in the CelVivo sales ammunition kit?	/sources/sales-ammunition.md
What is the China 261-dealer map?	/sources/distributors-china-2026.md
Who is Robin actively working with?	/sources/agents.md
What is the work-rhythm cadence?	/sources/vault-mtime-snapshot-2026-07-16.md
What does the CelVivo 2026 whitepaper say?	/sources/literature-celvivo-brain-whitepaper-2026.md
What does the Bosnjakovic 2025 PAH paper say?	/sources/literature-cel-bosnjakovic-2025-pah-deepread.md
What is the Raji 2026 hMOs + 3Brain story?	/sources/literature-raji-2026-deepread.md
What is the Tasevska 2025 BIO X SSE story?	/sources/literature-tasevska-2025-deepread.md
How does the agent stack consume this output?	/themes/03-ai-agents.md
How does the local-LLM fleet host this evidence?	/themes/04-local-llm.md
Where does CelVivo + 3Brain output land?	/themes/01-organoid-equipment.md
Where does Cellink output land?	/themes/02-bioprinting.md
What does Quintard 2024 say about vascularized organoid chips?	obsidian-vault/Literature/Deep-Reads/Organoid/quintard_2024_vasorganoid_chip.md (vault path; deep-read synthesis not yet split out to /sources/)
What does Guo 2026 say about organoid IRB ethics?	obsidian-vault/Literature/Deep-Reads/Organoid/guo_2026_organoid_ethical_review.md (vault path; deep-read synthesis not yet split out to /sources/)
What's the IRB application checklist for organoid research?	templates/类器官IRB申请清单.md v1.0 (vault path; untracked)
What's the IRB application checklist for organoid research?	templates/类器官IRB申请清单.md v1.0 (vault path; untracked)